Strong Signal for Investors and Partners: H2 Global Group and VR LIFE Validate the Value of European MedTech Innovation
VR LIFE’s valuation growth, clinical traction, and planned U.S. entry reinforce H2 Global Group’s broader MedTech value creation strategy PRAGUE, CZECH REPUBLIC, April 7, 2026 /EINPresswire.com/ -- European MedTech innovator H2 Global Group is …